Addus HomeCare (ADUS)
(Real Time Quote from BATS)
$92.28 USD
-3.22 (-3.37%)
Updated Apr 25, 2024 12:40 PM ET
2-Buy of 5 2
B Value B Growth B Momentum A VGM
Average Brokerage Rating
Current ABR | 1.67 |
ABR (Last week) | 1.44 |
# of Recs in ABR | 9 |
Average Target Price | $108.50 |
LT Growth Rate | 11.60% |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 154 of 252 |
Current Quarter EPS Est: | 1.10 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 1 | 1 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 0 | 0 | 0 | 0 |
ABR | 1.67 | 1.44 | 1.44 | 1.25 | 1.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/27/2024 | Raymond James | John W Ransom | Moderate Buy | Moderate Buy |
2/5/2024 | William Blair | Jared Haase | Not Available | Strong Buy |
11/2/2023 | Stephens | Scott Fidel | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.